Search


Current filters:
Start a new search
Add filters:

Use filters to refine the search results.


Results 61-70 of 253 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2015Jurisdictional differences in opioid use, other licit and illicit drug use, and harms associated with substance use among people who tamper with pharmaceutical opioidsPeacock, A.; Bruno, R.; Cama, E.; Kihas, I.; Larance, B.; Lintzeris, N.; Hordern, A.; White, N.; Ali, R.; Degenhardt, L.
2014Association of innate immune single-nucleotide polymorphisms with the electroencephalogram during desflurane general anaesthesiaMulholland, C.; Somogyi, A.; Barratt, D.; Coller, J.; Hutchinson, M.; Jacobson, G.; Cursons, R.; Sleigh, J.
2014Cannabinoid effects on β amyloid fibril and aggregate formation, neuronal and microglial-activated neurotoxicity in vitroJanefjord, E.; Maag, J.; Harvey, B.; Smid, S.
2014Validation of an LC-MS/MS method for the quantification of mycophenolic acid in human kidney transplant biopsiesMd Dom, Z.; Noll, B.; Coller, J.; Somogyi, A.; Russ, G.; Hesselink, D.; van Gelder, T.; Sallustio, B.
2014Controlled release and bioactivity of the monoclonal antibody rituximab from a porous matrix: a potential in situ therapeutic deviceSimovic, S.; Diener, K.; Bachhuka, A.; Kant, K.; Losic, D.; Hayball, J.; Brown, M.; Vasilev, K.
20145-HT₁B receptor modulation of the serotonin transporter in vivo: studies using KO miceMontanez, S.; Munn, J.; Owens, W.; Horton, R.; Daws, L.
2013Phase I, pharmacokinetic and pharmacodynamic evaluation of CYT997, an orally-bioavailable cytotoxic and vascular-disrupting agentBurge, M.; Francesconi, A.; Kotasek, D.; Fida, R.; Smith, G.; Wilks, A.; Vasey, P.; Lickliter, J.
2014Lethal hepatocellular necrosis associated with herbal polypharmacy in a patient with chronic hepatitis B infectionGilbert, J.; Musgrave, I.; Hoban, C.; Byard, R.
2018Characterization of isolated liver sinusoidal endothelial cells for liver bioengineeringDingle, A.M.; Yap, K.K.; Gerrand, Y.W.; Taylor, C.J.; Keramidaris, E.; Lokmic, Z.; Kong, A.M.; Peters, H.L.; Morrison, W.A.; Mitchell, G.M.
2014Individual differences underlying susceptibility to addiction: role for the endogenous oxytocin systemBuisman-Pijlman, F.; Sumracki, N.; Gordon, J.; Hull, P.; Carter, C.; Tops, M.